After Hours
$
164.30
Change
+0.75 +0.46%
Volume
Volume 329,643
Jan 22, 2021, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 161.73
$ 163.55
Change
+1.82 +1.13%
Day low
Day high
$161.87
$165.16

52 week low
52 week high
$109.16
$165.16

Market cap
$425.76B
Average volume
7.54M
P/E ratio
25.70
Rev. per Employee
$621,127
EPS
6.36
Dividend
1.01
Div yield
2.47%
Ex dividend date
2/22/21
MarketWatch News on JNJ
-
FDA approves first long-acting HIV drug combination
- Associated Press
-
Hungary Approves Russia’s Covid-19 Vaccine
- Josh Nathan-Kazis
-
Johnson & Johnson stock price target raised to $170 from $160 at UBS
- Tomi Kilgore
-
Fear Comes to the Stock Market. What Comes Next.
- Ben Levisohn
-
Barron’s 2020 Quiz Winner Gets an Unusually High Score
- Andrew Bary
-
Global Dividends Will Rise 7% in 2021, IHS Markit Says, but U.S. Payouts Seen Falling
- Lawrence C. Strauss
-
Dow's 69-point climb highlighted by gains for shares of Intel, Chevron
- MarketWatch Automation
-
Boeing, Johnson & Johnson share gains contribute to Dow's 150-point climb
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Analysts Are Overwhelmingly Bullish on Abbott Laboratories
- MarketRealist.com
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Wall Street’s Views on BSX’s Acquisition of Cryterion Medical
- MarketRealist.com
Other News on JNJ
-
Sana Biotechnology Seeks $150 Million U.S. IPO
- Seeking Alpha
-
Q4 and 2021 Earnings Estimates Keep Going Up
- Zacks.com
-
Realty Income Is A Slam Dunk Below $60
- Seeking Alpha
-
Regional Banks Post Mixed Earnings Results
- Zacks.com
-
How Long It Will Take to Get Vaccines to Most Americans
- Jessica Wang
-
Wall Street Breakfast: Loon Goes Pop
- Seeking Alpha
-
Purell Maker Bets Sanitizing Habits Outlast the Pandemic
- Sharon Terlep
-
2020 Portfolio Activity Summary And 2021 Target
- Seeking Alpha
-
Why is U.S. vaccine rollout taking longer than expected?
- Seeking Alpha
-
FDA OK's Janssen's HIV drug combo Cabenuva
- Seeking Alpha
-
- Seeking Alpha
-
Distillate Capital Partners 2020 Year-End Letter To Investors
- Seeking Alpha
-
Epilepsy Drug News: Why Addex Therapeutics (ADXN) Stock Is Soaring Today
- InvestorPlace.com
-
Medical Device Aristocrats For A High Class Dividend Portfolio
- Seeking Alpha
- Loading more headlines...
Press Releases on JNJ
-
- Baystreet.ca
-
Best Biotech Stocks For 2021? 3 Names Trending This Week
- StockMarket.com
-
- Baystreet.ca
-
Four Game-Changing Medical Cannabis Small Caps
- IAM Newswire
-
Hemostats Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025
- SUPER MARKET RESEARCH
-
Daily Dividend Report: CVS,JNJ,RPM,AFIN,AFG
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2021
- PR Newswire - PRF
-
Psychedelics Industry Gearing Up For an Even Bigger 2021
- Financial News Media
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com